Abstract
Purpose
To clarify the prognostic factors for recently revised stage IB non-small cell lung cancer.
Methods
Twenty-six specimens of completely resected stage IB (pT2aN0M0) non-small cell lung cancer were studied. Clinicopathological profiles of the 26 patients, including age, sex, smoking status, tumor size, histology, pleural invasion, and lymphatic and blood vessel invasion, were assessed. Correlation between tumor recurrence and these factors was assessed by statistical analysis.
Results
Lymphatic vessel invasion was the only statistically significant factor for postoperative tumor recurrence as assessed by multivariate analysis. Kaplan-Meier survival curves showed a 5-year recurrence-free rate of 77.8% in 26 patients with no lymphatic vessel invasion compared with 28.6% in those with lymphatic vessel invasion.
Conclusion
Lymphatic vessel invasion of cancer cells was indicated as an independent prognostic factor in revised stage IB non-small cell lung cancer.
Similar content being viewed by others
References
Poleri C, Morero JL, Nieva B, Vazquez MF, Rodriguez C, de Titto E, et al. Risk of recurrence in patients with surgically resected stage I non-small cell lung cancer. Chest 2003;123: 1858–1867.
Rami-Porta R, Ball D, Crowley J, Giroux DJ, Jett J, Travis WD, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for the lung cancer. J Thorac Oncol 2007;2:593–602.
Zhou Q, Suzuki K, Anami Y, Oh S, Takamochi K. Clinicopathologic features in resected subcentimeter lung cancer: status of lymph node metastases. Interact Cardiovasc Thorac Surg 2010;10:53–57.
Hashizume S, Nagayasu T, Hayashi T, Hidaka S, Tsuchiya T, Tagawa T, et al. Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer. Lung Cancer 2009;65:363–370.
Adachi Y, Nakamura H, Kitamura Y, Taniguchi Y, Araki K, Shomori K, et al. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with antipodoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases. Pathol Int 2007;57:171–177
Kadota K, Huang CL, Liu D, Ueno M, Kushida Y, Haba R, et al. The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. Eur J Cancer 2008;44:1057–1067.
Tsuchiya T, Akamine S, Muraoka M, Kamohara R, Tsuji K, Urabe S, et al. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer 2007;56:341–348.
Shoji F, Haro A, Yoshida T, Ito K, Morodomi Y, Yano T, et al. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer. Ann Thorac Surg 2010;89:864–869.
Nanashima A, Shibata K, Nakayama T, Tobinaga S, Araki M, Kunizaki M, et al. Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma. Ann Surg Oncol 2009;16:2130–2137.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Araki, K., Adachi, Y., Metsugi, H. et al. Prognostic implication of lymphatic vessel invasion in stage IB (pT2aN0M0) non-small cell lung cancer. Gen Thorac Cardiovasc Surg 59, 605–608 (2011). https://doi.org/10.1007/s11748-011-0782-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-011-0782-4